Screener
Intellia Therapeutics NTLA Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating loss | (112,760) | (109,996) | (213,292) | (230,803) |
| Other income, net: | ||||
| Interest income | 5,797 | 7,402 | 11,002 | 16,005 |
| Change in fair value of investments, net | 329 | 1,339 | (575) | (786) |
| Total other income, net | 6,126 | 8,741 | 10,427 | 15,219 |
| Net loss | $(106,634) | $(101,255) | $(202,865) | $(215,584) |
| Net loss per share, basic and diluted | $(0.80) | $(0.98) | $(1.61) | $(2.08) |
| Weighted average shares outstanding, basic and diluted | 133,480 | 103,732 | 126,057 | 103,617 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's gain (loss) on disposal of assets?
- Intellia Therapeutics (NTLA) reported gain (loss) on disposal of assets of $329K in Q2 2026.
- How has Intellia Therapeutics's gain (loss) on disposal of assets changed year-over-year?
- Intellia Therapeutics's gain (loss) on disposal of assets decreased by 75.4% year-over-year, from $1.34M to $329K.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about Intellia Therapeutics's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude